PHARDEN
The computed 12-month bankruptcy probability of PHARDEN is 0.5% (very low). The company has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 33 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 03-06-2026 | 2026-00138396 |
| 31-12-2024 | volledig | 02-06-2025 | 2025-00118283 |
| 31-12-2023 | volledig | 25-07-2024 | 2024-00285224 |
| 31-12-2022 | volledig | 30-08-2023 | 2023-00383622 |
| 31-12-2021 | volledig | 31-12-2022 | 2023-20555255 |
| 31-12-2020 | volledig | 16-07-2021 | 2021-38600045 |
| 31-12-2019 | volledig | 21-10-2020 | 2020-62200155 |
| 31-12-2018 | volledig | 29-07-2019 | 2019-40200242 |
| 31-12-2017 | volledig | 12-07-2018 | 2018-32300489 |
| 31-12-2016 | volledig | 28-09-2017 | 2017-64700039 |
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 18-02-1993 |
| Status | Active |
| Postal code | 5555 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 91015B0300/00X007 | Wallonia | 1,726 m² | 1 · 254 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
26-01-2022 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": "0778.778.554",
"rrn": null,
"kind": "org",
"name": "srl DR PHARMA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2022-01-14",
"act_kind_objet": "Obiet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2022-01-04",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2021-12-31"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0449.472.066",
"name_full": "PHARDEN",
"legal_form": "SA",
"_kbo_filled_from_list": true,
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [
{
"kbo": "0778.778.554",
"pct": null,
"kind": "org",
"name": "srl DR PHARMA",
"role": "aandeelhouder",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "monsieur Cyrille REGNIER",
"role": "g\u00E9rant_statutaire",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "monsieur Beno\u00EEt CLOSSON",
"role": "g\u00E9rant_statutaire",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "sri CLOSSON",
"role": "commanditaire",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "madame sylvie BRASSEUR",
"role": "commanditaire",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | PHARDEN |